// App-Quantinova.ai

OP0251 : THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) SCORE – A NEW PATIENT-REPORTED OUTCOME MEASURE FOR PATIENTS WITH SYSTEMIC SCLEROSIS

Researchers

Presenter

  • M. O. Becker

Principal Investigators

  • K. Fligelstone

  • A. Roennow

  • Y. Allanore

  • P. Carreira

  • L. Czirjk

  • C. Denton

  • R. Hesselstrand

  • G. Sandqvist

  • O. Kowal-Bielecka

  • C. Bruni

  • M. Matucci Cerinic

  • C. Mihai

  • A. M. Gheorghiu

  • U. Mller-Ladner

  • J. Sexton

  • T. Heiberg

  • O. Distler

Medical Centers

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

  • NCRI, London, United Kingdom

  • FESCA, Aalborg, Denmark

  • Department of Rheumatology, University Paris Descartes and Cochin Hospital, Paris, France

  • Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain

  • Department of Immunology and Rheumatology, Faculty of Medicine, University of Pecs, Pecs, Hungary

  • Centre for Rheumatology, Royal Free and University College London Medical School, Royal Free Campus, London, United Kingdom

  • Department of Pathology Lund University, Lund, Sweden

  • Department of Endocrinology and Diabetes with Internal Medicine, Medical University in Bialystok, Bialystok, Poland

  • Division of Medicine and Rheumatology, University of Florence, Florence, Italy

  • Internal Medicine and Rheumatology Department Sf. Maria Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

  • Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Kerckhoff Klinik Bad Nauheim, Bad Nauheim, Germany

  • Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

  • Department of Health and Social Sciences, Oestfold University College, Oslo, Norway

Locations

  • Switzerland

  • United Kingdom

  • Denmark

  • France

  • Spain

  • Hungary

  • Sweden

  • Poland

  • Italy

  • Romania

  • Germany

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • BMS Infotech

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved